XML 95 R83.htm IDEA: XBRL DOCUMENT v3.3.1.900
Note 13 - Stock Based Compensation (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 18, 2014
Dec. 31, 2015
Dec. 31, 2014
Note 13 - Stock Based Compensation (Details) [Line Items]      
Allocated Share-based Compensation Expense   $ 137 $ 58
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares) 165,000 0  
Employee Stock Option [Member]      
Note 13 - Stock Based Compensation (Details) [Line Items]      
Allocated Share-based Compensation Expense   $ 75 2
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 2.01%    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term 7 years 6 months    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 26.00%    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 0.00%    
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized   $ 301  
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition   4 years  
Restricted Stock [Member]      
Note 13 - Stock Based Compensation (Details) [Line Items]      
Allocated Share-based Compensation Expense   $ 62 $ 56
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized   $ 184  
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in Shares)   132,000  
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period   5 years  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in Dollars per share)   $ 7.91 $ 6.25
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in Shares)   10,969 17,268